Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd plus vitamin D for prevention of type 1 diabetes in autoantibody-positive children
2014-003755-64Phase 2Completed
- Sponsor
- Helena Elding Larsson
- Start
- Sep 2014
- Modality
- Small Molecules, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Diamyd plus vitamin D with Placebo plus vitamin D (2 arms). Primary endpoint: Proportion diagnosed with clinical type 1 diabetes. Started Sep 2014; status: completed.
02
Drugs
Diamydcholecalciferol
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-003755-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003755-64.